Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15717655rdf:typepubmed:Citationlld:pubmed
pubmed-article:15717655lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C0001618lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C0243161lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C0019409lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C2349209lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C1549649lld:lifeskim
pubmed-article:15717655lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:15717655pubmed:issue6lld:pubmed
pubmed-article:15717655pubmed:dateCreated2005-2-18lld:pubmed
pubmed-article:15717655pubmed:abstractTextAdrenal incidentalomas are detected more frequently with high-resolution imaging modalities. It is difficult to distinguish between benign and malignant lesions despite the so-called histologic Weiss criteria, imaging features, and molecular studies. We here present a 52 yr-old man who was found to have an adrenal incidentaloma during an annual check-up at his urologist. An 8 cm large adrenal lesion was detected on ultrasound, computed tomography, and magnetic resonance imaging with imaging features suggestive of malignancy. The lesion was hormonally inactive. A left-sided adrenalectomy was performed and histologic grading revealed a Weiss score of 2, suggesting a benign tumor. However, on further follow-up, the patient developed a local recurrence and pulmonary metastases diagnosed 6 yr after initial presentation. After repeat surgery in the left adrenal bed adrenocortical tumor tissue had a Weiss score of 8, clearly suggesting histologic malignancy. The patient received adjuvant mitotane therapy. Under this therapy, he developed a right-sided adrenal mass (contralateral from the primary tumor) of 2 cm size which disappeared during the following 9 months, whereas the pulmonary metastases remained unchanged, suggesting tumor clones with a variable response to treatment or spontaneous apoptosis. This case suggests that adrenal incidentalomas larger than 6 cm with imaging features such as intratumoral necrosis suggestive of malignancy, should be managed as potential cancers independent of the so-called Weiss criteria. In such patients, close follow-up examinations including high-resolution imaging (preferably 3 monthly) are needed and should be carried out by a physician familiar/specialized in endocrine oncology.lld:pubmed
pubmed-article:15717655pubmed:languageenglld:pubmed
pubmed-article:15717655pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15717655pubmed:citationSubsetIMlld:pubmed
pubmed-article:15717655pubmed:statusMEDLINElld:pubmed
pubmed-article:15717655pubmed:monthJunlld:pubmed
pubmed-article:15717655pubmed:issn0391-4097lld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:SchmidtFFlld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:HULLR NRNlld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:PaschkeRRlld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:EichfeldUUlld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:FührerDDlld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:PohlinkCClld:pubmed
pubmed-article:15717655pubmed:authorpubmed-author:TannapfeAAlld:pubmed
pubmed-article:15717655pubmed:issnTypePrintlld:pubmed
pubmed-article:15717655pubmed:volume27lld:pubmed
pubmed-article:15717655pubmed:ownerNLMlld:pubmed
pubmed-article:15717655pubmed:authorsCompleteYlld:pubmed
pubmed-article:15717655pubmed:pagination565-9lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:meshHeadingpubmed-meshheading:15717655...lld:pubmed
pubmed-article:15717655pubmed:year2004lld:pubmed
pubmed-article:15717655pubmed:articleTitleDoes tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?lld:pubmed
pubmed-article:15717655pubmed:affiliationDepartment of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany.lld:pubmed
pubmed-article:15717655pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15717655pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15717655lld:pubmed